Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CPhI Worldwide and CPhI Pharma Evolution, part of UBM Live’s Pharmaceutical Portfolio, announce the conclusions of its first monthly report into the current status of the formulation and ingredients market- conducted amongst high level executives and...
read more
Wednesday, November 27, 2013
CPhI Worldwide, organised by UBM Live, celebrates the closing of its most successful show to date with pre-audit figures estimating more than 34,000 attendees and 2,200 exhibitors. Held in Frankfurt, the show hosted senior-level decision makers and ...
read more
Friday, November 14, 2014
CPhI Worldwide, organised by UBM Live, celebrates the closing of its most successful show to date with pre-audit figures estimating more than 36,000+ attendees and 2,500 exhibitors. Held this year in Paris, the show hosted senior-level decision ...
read more
Thursday, January 22, 2015
CPhI Worldwide, organised by UBM EMEA, has started the New Year by announcing the launch of a new advisory board designed to bolster the experience provided by the global event portfolio and supporting brands to both exhibitors and visitors.
read more
CPhI Worldwide, organised by UBM EMEA, announces its Expert Panel for CPhI Worldwide 2015 ahead of the eagerly anticipated annual report (3rd edition) – to be released September and October 2015, in three parts. The report presents a holistic ...
read more
Pharma event launches a range of packages for industry partners to implement charity giving.
read more
Croda broke ground on 9 May 2023 on its newest manufacturing facility in Lamar, Clinton County, Pennsylvania.
read more
Crystal Pharmatech, a leading contract research organization (CRO) which focuses on solid state information for active pharmaceutical ingredients and formulations, has more than quadrupled since it was founded three years ago in 2010 by Dr. Alex Chen...
read more
Tuesday, December 05, 2017
CSL and Vitaeris have entered into a collaboration and purchase option agreement to expedite the development of clazakizumab as a therapeutic option for solid organ transplant rejection.
read more
Wednesday, February 05, 2020
CURE Pharmaceutical has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s pharmaceutical groups specialized in medicinal cannabis products.
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
Cytovance Biologics, Inc. announces that it has teamed up with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions.
read more
Dalton Pharma Services announced that the FDA completed a PAI inspection of its Health-Canada licensed manufacturing facility in Canada, in January 2019.
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Wednesday, September 18, 2019
Darmerica is voluntarily recalling two lots, DR4654A and DL4654A, of Quinacrine Dihydrochloride, bulk API powder packaged in Amber HDPE Bottles to the consumer level.
read more